Reports - Press Releases

Date	Title	Company
21-Jan-2026	Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI	ACCESS Newswire
21-Jan-2026	Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign	ACCESS Newswire
21-Jan-2026	Ensysce Biosciences Expands Global Opioid Patent Portfolio	ACCESS Newswire
21-Jan-2026	Ascelia Pharma Announces Deputy CEO Julie Waras Brogren to Leave the Company	ACCESS Newswire
21-Jan-2026	Senzime Secures Major Ivy League US Hospital System Contract	ACCESS Newswire
21-Jan-2026	iZafe Group Launches Modular Display and Remote Care System - One Dosell for All Users	ACCESS Newswire
21-Jan-2026	BioNxt Reports Final Preclinical Results Demonstrating Approximately 40% Higher Cladribine Delivery for the Treatment Multiple Sclerosis (MS)	ACCESS Newswire
21-Jan-2026	FluoGuide Submits an IND for FG001, to Initiate First U.S. Registration Trial	ACCESS Newswire
21-Jan-2026	SoftWriters Strengthens Leadership Team with Addition of LiAna Tschen and Strategic Role Expansions	ACCESS Newswire
21-Jan-2026	Dispense Times Releases New Issue Featuring Mark Cuban, Offering Clarity for Independent Pharmacy Owners	ACCESS Newswire
20-Jan-2026	Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference	ACCESS Newswire
20-Jan-2026	Aytu BioPharma Recaps Investor Day Held on January 20, 2026	ACCESS Newswire
20-Jan-2026	Surgical Information Systems (SIS) Earns Eleventh Consecutive #1 Client Rating in Ambulatory Surgical Center IT User Satisfaction, Black Book 2026 Survey	ACCESS Newswire
20-Jan-2026	Saint Therese of Oxbow Lake Earns 2025 Zellner Group Client of the Year Award	ACCESS Newswire
20-Jan-2026	Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA	ACCESS Newswire
20-Jan-2026	Black Book Research Releases "New Zealand Acute Care EMR & Digital Health 2026" Companion Report	ACCESS Newswire
20-Jan-2026	Regentis' GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method	ACCESS Newswire
20-Jan-2026	Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office	ACCESS Newswire
20-Jan-2026	Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief	ACCESS Newswire
20-Jan-2026	Moderna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection	ACCESS Newswire